CSTONE PHARMACEUTICALS earnings per share and revenue

2616 earnings per share for the last semiannual are -0.09 HKD whereas the estimation was -0.03 HKD which accounts for -166.67% surprise. Company revenue for the same period amounts to 162.89 M HKD despite the estimated figure of 334.88 M HKD. Estimated earnings per share for the next semiannual are -0.11 HKD, and revenue is expected to reach 117.71 M HKD. Also watch annual changes over time to get a bigger picture of 2616 earnings per share and revenue dynamics.